Is GSK A Good Choice For Dividend Investors? | Seeking Alpha
Will GlaxoSmithKline deal be worth it for Unilever?
GSK to boost spending power of pharma business post break-up
GSK's Emma Walmsley becomes highest-paid female FTSE 100 chief | GlaxoSmithKline | The Guardian
GSK India reports Rs 133 crore net profit in quarter four of FY23 - The Economic Times
Financial Ratio Analysis of AstraZeneca and GlaxoSmithKline
GlaxoSmithKline Needs More Cash to Catch Up on the Science - Bloomberg
First female CEO of GSK to be paid 25% less than her male predecessor
GSK Pharmaceuticals India: net assets 2022 | Statista
GSK's drugs arm to get $11 bln booster from consumer spin-off | Reuters
GlaxoSmithKline : Top 20 Pharmaceutical Companies in 2021 | Contract Pharma
GSK plc - Wikipedia
GSK (LSE:GSK) - Stock Price, News & Analysis - Simply Wall St
GSK to buy US biotech group Affinivax in $3bn deal | Financial Times
Glaxosmithkline Pharma Q1 Results: Net profit rises 8% to Rs 116 crore - The Economic Times
GSK to buy Bellus for $2 billion to gain cough medicine - Times of India
GSK to create up to 5,000 jobs as it plans huge biotech centre | Financial Times
GlaxoSmithKline (GSK): What Could Give Us An Upside Here | Seeking Alpha
GlaxoSmithKline Deal for Tesaro: It's the Wrong Medicine - Bloomberg
Why GSK should turn down Unilever's billions | MoneyWeek
Are GSK's legal troubles a threat to the firm's survival? | MoneyWeek
Clouds Are Gathering (Again) For GSK | Seeking Alpha
GSK delivers FY 2021 reported sales of £34 billion, stable at AER, +5% CER; Total EPS 87.6p -24% AER, -13% CER and Adjusted EPS of 113.2p -2% AER, +9% CER | GSK
GSK shown up by AstraZeneca yet again | Financial Times
